These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 681005)

  • 1. Antithrombogenicity of immobilized urokinase--clinical application.
    Sugitachi A; Takagi K
    Int J Artif Organs; 1978 Mar; 1(2):88-92. PubMed ID: 681005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombogenicity of UK-immobilized polymer surfaces.
    Sugitachi A; Tanaka M; Kawahara T; Takagi K
    Trans Am Soc Artif Intern Organs; 1980; 26():274-8. PubMed ID: 7018054
    [No Abstract]   [Full Text] [Related]  

  • 3. Immobilization of plasminogen activator, urokinase, on nylon.
    Sugitachi A; Takagi K; Imaoka S; Kosaki G
    Thromb Haemost; 1978 Apr; 39(2):426-36. PubMed ID: 580991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombogenicity of immobilized urokinase and its clinical significance.
    Sugitachi A; Kawahara T; Kodama J; Kikkawa Y; Takagi K
    Blut; 1978 Jul; 37(1):31-6. PubMed ID: 667367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on antithrombogenicity of urokinase immobilized polymer].
    Yabushita Y; Suyama K; Takagi K; Sugitachi A
    Yakugaku Zasshi; 1988 Jan; 108(1):44-9. PubMed ID: 3385607
    [No Abstract]   [Full Text] [Related]  

  • 6. The in vitro and in vivo behavior of urokinase immobilized onto collagen-synthetic polymer composite material.
    Watanabe S; Shimizu Y; Teramatsu T; Murachi T; Hino T
    J Biomed Mater Res; 1981 Jul; 15(4):553-63. PubMed ID: 7024280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolytic activity of immobilized plasminogen activator.
    Senatore FF; Bernath FR
    Res Commun Chem Pathol Pharmacol; 1985 Aug; 49(2):295-304. PubMed ID: 4059655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo studies on antithrombogenicity of poly(propylene oxide) segmented nylon 610 in relation to its crystalline-amorphous microstructure.
    Yui N; Kataoka K; Sakurai Y; Aoki T; Sanui K; Ogata N
    Biomaterials; 1988 May; 9(3):225-9. PubMed ID: 3408792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase-immobilization suppresses inflammatory responses to polyurethane tubes implanted in rabbit muscles.
    Lai ZF; Imamura T; Koike N; Kitamoto Y
    J Biomed Mater Res A; 2006 Jan; 76(1):81-5. PubMed ID: 16224782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical application of the urokinase-immobilized polyurethane catheter].
    Matsumoto M; Okamoto Y; Konishi Y; Nomoto S; Soneda J; Fujiwara Y; Nishimura K; Ban T; Suyama K
    Nihon Geka Hokan; 1986 Sep; 55(5):727-31. PubMed ID: 3579460
    [No Abstract]   [Full Text] [Related]  

  • 11. Sulfonated poly(vinylidene fluoride) as a biomaterial: immobilization of urokinase and biocompatibility.
    Aoshima R; Kanda Y; Takada A; Yamashita A
    J Biomed Mater Res; 1982 May; 16(3):289-99. PubMed ID: 7045128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activity of urokinase immobilized to cross-linked poly(2-hydroxyethyl methacrylate).
    Liu LS; Ito Y; Imanishi Y
    Biomaterials; 1991 Aug; 12(6):545-9. PubMed ID: 1772951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The changes of alpha 2-plasmin inhibitor, and notably urokinase activities in blood measured by synthetic chromogenic substrates S-2444 after urokinase administration].
    Itoh Y; Tsuji K; Tanaka N; Yamada M; Nakanishi M; Ishihara M; Kobayashi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jan; 35(1):68-76. PubMed ID: 6338134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic mechanisms of urokinase immobilized polyurethane.
    Kitamoto Y; Tomita M; Kiyama S; Inoue T; Yabushita Y; Sato T; Ryoda H; Sato T
    Thromb Haemost; 1991 Jan; 65(1):73-6. PubMed ID: 2024241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysis time and FDP immunoprecipitation by soluble and immobilized urokinase.
    Senatore F; Bernath F
    J Biomed Mater Res; 1986 Feb; 20(2):189-203. PubMed ID: 2937789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biphasic nature and temperature dependence of the activation of human plasminogen by urokinase. A simple urokinase assay based on this phenomenon.
    Ambrus CM; Bartfay-Szabo A; Mirand E; Ambrus JL
    Res Commun Chem Pathol Pharmacol; 1979 May; 24(2):339-47. PubMed ID: 461988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of antithrombogenicity of a new heparinized hydrophilic polymer: chronic in vivo studies and clinical application.
    Idezuki Y; Watanabe H; Hagiwara M; Kanasugi K; Mori Y
    Trans Am Soc Artif Intern Organs; 1975; 21():436-49. PubMed ID: 1146018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the properties of immobilized urokinase: effects of pH and temperature.
    Yabushita Y
    Biotechnol Appl Biochem; 1988 Jun; 10(3):294-300. PubMed ID: 3395470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on metabolism of urokinase and mechanism of thrombolysis by urokinase.
    Ueno T; Kobayashi N; Maekawa T
    Thromb Haemost; 1979 Oct; 42(3):885-94. PubMed ID: 505403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.